Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
8
×
life sciences
national blog main
boston top stories
national top stories
biotech
new york blog main
new york top stories
san francisco blog main
san francisco top stories
seattle blog main
startups
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
amgen
biogen
boston
crispr
editas medicine
gene editing
gilead sciences
indiana blog main
indiana top stories
novartis
venture capital
What
ceo
8
×
bio
roundup
acquisitions
crispr
drug
medicine
medicines
week
announced
big
biggest
daniel
editas
gilead
katrine
moves
o’day
sciences
test
aces
acquisition
aims
albert
allergan
amazon’s
backed
blessing
bosley
bosley's
bosley’s
bourla
bridge
bucks
build
buy
cas
cause
check
cholesterol
Language
unset
unknown
Current search:
" boston blog main "
×
ceo
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play